This inventor holds 2 USPTO granted patents. Top assignee: King Abdulaziz University. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Khadijah A Mohammad: Innovator in Antimicrobial Compounds and Cancer Treatment
Introduction
Khadijah A Mohammad is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the fields of antimicrobial compounds and cancer treatment. With a total of 2 patents, her work is recognized for its potential impact on healthcare.
Latest Patents
Khadijah's latest patents include innovative solutions for combating infections and treating cancer. One of her notable inventions is the development of potent antimicrobial compounds with a pyridazine nucleus. These compounds exhibit antibiotic properties and are particularly effective against drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Another significant patent involves arylacetamides as AMP-activated protein kinase inhibitors, which are aimed at treating breast and pancreatic cancer. This patent describes therapeutic compounds that incorporate an arylacetamide core with a pending N-benzyl group, along with pharmaceutical compositions for their application.
Career Highlights
Khadijah A Mohammad is affiliated with King Abdulaziz University, where she continues her research and development in the field of pharmaceuticals. Her academic and professional journey reflects her dedication to advancing medical science and improving patient outcomes.
Collaborations
Khadijah has collaborated with esteemed colleagues, including Abdelsattar Mansour Omar and Moustafa Elsayed El-Araby. These partnerships enhance her research efforts and contribute to the innovative solutions she develops.
Conclusion
Khadijah A Mohammad stands out as a leading inventor in the realm of antimicrobial and cancer treatment innovations. Her patents not only showcase her expertise but also hold promise for addressing critical health challenges.